Year: 2012

It’s all in the timing

Shanghai Fosun Pharmaceutical last week pushed back the launch of its US$600 million Hong Kong initial public offering from 11 October to, most likely, 15 October – possibly putting it on track for an accelerated marketing timetable. (See my prior column in Money Post on 30 April). read

, , , , , , , Accountants, Anchor investors, China... +5 more

HKEx does some Seoul searching

A hardly noticed piece of news was released by the Hong Kong exchange on August 30: companies incorporated in South Korea will now be allowed to list in Hong Kong. Korea will accordingly join a list of 19 other jurisdictions now recognised by the exchange – on top of the mainland, Bermuda, the Cayman Islands and, of course, Hong Kong itself. read

, , , , Dual listings, Hong Kong, Listing by introduction... +2 more

‘Add £10,000 for good luck’

One of the perks of working in an investment bank is – or rather was – a fairly casual approach to expenses. Virtually everything is billable back to the employer, who directly or indirectly passes the expenses onto clients. read

, , Expenses, Fees, UK